When THC attaches to the receptor, the effect is like an off switch to a light bulb, effectively turning "off" the pain. But ...
The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback